Cargando…
Prognostic Significance and Clinicopathological Associations of COX-2 SNP in Patients with Nonsmall Cell Lung Cancer
Background. To further improve the screening, diagnosis, and therapy of patients with nonsmall cell lung cancer (NSCLC) additional diagnostic tools are urgently needed. Gene expression of Cyclooxygenase-2 (COX-2) has been linked to prognosis in patients with NSCLC. The role of the COX-2 926G>C Si...
Autores principales: | Grimminger, Peter P., Stöhlmacher, Jan, Vallböhmer, Daniel, Schneider, Paul M., Hölscher, Arnulf H., Metzger, Ralf, Danenberg, Peter V., Brabender, Jan |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2793422/ https://www.ncbi.nlm.nih.gov/pubmed/20016751 http://dx.doi.org/10.1155/2009/139590 |
Ejemplares similares
-
Differential SPARC mRNA expression in Barrett's oesophagus
por: Brabender, J, et al.
Publicado: (2003) -
Clinicopathological and prognostic significance of COX-2 in glioma patients: a meta-analysis
por: Wang, Jun, et al.
Publicado: (2022) -
Loss of heterozygosity at thymidylate synthase locus in Barrett's metaplasia, dysplasia, and carcinoma sequences
por: Kuramochi, Hidekazu, et al.
Publicado: (2009) -
Clinicopathological and prognostic significance of COX-2 immunohistochemical expression in breast cancer: a meta-analysis
por: Xu, Feng, et al.
Publicado: (2016) -
Prognostic significance of L-type amino acid transporter 1 expression in resectable stage I–III nonsmall cell lung cancer
por: Kaira, K, et al.
Publicado: (2008)